The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

MEDNAX Inc

NYSE: MD
Last

(U.S.) $72.67

Today's change-0.67 -0.91%
Updated April 17 4:02 PM EDT. Delayed by at least 15 minutes.
 

MEDNAX Inc

NYSE: MD
Last

(U.S.) $72.67

Today's change-0.67 -0.91%
Updated April 17 4:02 PM EDT. Delayed by at least 15 minutes.

MEDNAX Inc down (U.S.)$0.67

MEDNAX Inc closed lower Friday, dropping (U.S.)$0.67 or 0.91% to (U.S.)$72.67. Shares have lost 0.94% over the last five days, but sit 2.55% below their 52-week high. This security has outperformed the S&P 500 by 8.61% during the last year.

Key company metrics

  • Open(U.S.) $73.07
  • Previous close(U.S.) $73.34
  • High(U.S.) $73.42
  • Low(U.S.) $72.33
  • Bid / Ask-- / --
  • YTD % change+9.92%
  • Volume362,059
  • Average volume (10-day)340,837
  • Average volume (1-month)520,934
  • Average volume (3-month)556,586
  • 52-week range(U.S.) $49.82 to (U.S.) $74.57
  • Beta0.67
  • Trailing P/E22.85×
  • P/E 1 year forward20.62×
  • Forward PEG1.51×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.18
Updated April 17 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+13.01%

Based on its net profit margin of 13.01%, MEDNAX Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.17%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue651627596566
Total other revenue--------
Total revenue651627596566
Gross profit223210201173
Total cost of revenue428416395393
Total operating expense509488466462
Selling / general / administrative68616158
Research & development--------
Depreciation / amortization14111010
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income141138130104
Interest income (expense), net non-operating-3-2-2-1
Gain (loss) on sale of assets--------
Other--------
Income before tax139137128104
Income after tax88867964
Income tax, total51514941
Net income88867964
Total adjustments to net income--------
Net income before extra. items88867964
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items88867964
Inc. avail. to common incl. extra. items88867964
Diluted net income88867964
Dilution adjustment--------
Diluted weighted average shares99100100100
Diluted EPS excluding extraordinary itemsvalue per share0.890.860.790.64
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.890.860.790.64